PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 43 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

17 May 2025

  1. (diff | hist) m 20:04 Preparative HPLC purification 4,598 +36 RfC_Rasmus (talk | contribs) rm a duplicated category [rollback]
  2. (diff | hist) 18:52 Temperature excursion 6,150 +318 SupplyWatchSuri (talk | contribs) alphabetise the see-also list [rollback]
  3. (diff | hist) 14:35 Qingdao Sigma Chemical 11,582 +959 ReportReaderRilla (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  4. (diff | hist) 12:47 Peptide synthesis 4,134 ±0 FreightFenna (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  5. (diff | hist) m b 11:49 STEP trial programme 4,391 ±0 CiteBot (talk | contribs) bot: expand PMID to full citation [rollback]
  6. (diff | hist) 07:49 Shanghai Sigma-Audley New Material Technology 9,250 +355 FmocFrancis (talk | contribs) expand §Distribution and dispatch [rollback]
  7. (diff | hist) 06:35 VendorInvestigate 4,895 +707 LedgerLysander (talk | contribs) add the turnaround time the service publishes [rollback]
  8. (diff | hist) m 01:03 Subcutaneous injection 4,640 +559 BPC_Bramwell (talk | contribs) state the assumption that the whole vial is reconstituted at once [rollback]
  9. (diff | hist) 00:42 SURMOUNT trial programme 3,589 ±0 PreregPriya (talk | contribs) name the funder in the sentence, per PP:MOS [rollback]

16 May 2025

  1. (diff | hist) 13:12 Sangon Biotech 7,539 +116 FormularyFrida (talk | contribs) expand the product-scope row in the infobox [rollback]
  2. (diff | hist) 10:05 Talk:Flourishglobal Peptide Biotech 1,170 +108 CitationChaser (talk | contribs) /* State the packing, do not explain it */ reply
  3. (diff | hist) 09:21 International nonproprietary name 3,183 ±0 MazdutideMads (talk | contribs) fix the amino-acid substitution — position 8, not position 2 [rollback]
  4. (diff | hist) 08:53 Sterility testing 3,636 ±0 PeakShapePol (talk | contribs) unpipe a link that did not need piping [rollback]
  5. (diff | hist) 08:31 Talk:Reconstitution calculator 1,170 +90 AnalyticalAnnie (talk | contribs) /* Should the default vial mass be the gross or net figure? */ reply

15 May 2025

  1. (diff | hist) m b 23:10 Peptide content 6,898 ±0 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  2. (diff | hist) m 11:32 Insulin syringe 4,667 ±0 FiveOhThreeB (talk | contribs) correct the unit conversion — U-100 not U-40 [rollback]
  3. (diff | hist) m 10:01 Dose escalation schedule 4,073 ±0 PatientPanelPru (talk | contribs) clarify which volume the graduation marks measure [rollback]
  4. (diff | hist) 09:33 Talk:Beyond-use date 1,096 +176 GMP_Gita (talk | contribs) /* Category 2 table: which revision, and should earlier revisions be shown? */ reply
  5. (diff | hist) 09:03 Talk:Reconstitution calculator 959 +209 Chromatokid (talk | contribs) /* Should the default vial mass be the gross or net figure? */ reply
  6. (diff | hist) 08:50 Talk:Flourishglobal Peptide Biotech 959 +145 FreightFenna (talk | contribs) /* State the packing, do not explain it */ reply
  7. (diff | hist) 03:47 Third-party testing 6,906 +1,136 OrforglipronOona (talk | contribs) clarify that agreement between certificate and report is a weak finding [rollback]

14 May 2025

  1. (diff | hist) 16:40 Talk:Reconstitution calculator 748 +205 MolarMassMaeve (talk | contribs) /* Should the default vial mass be the gross or net figure? */ reply
  2. (diff | hist) 16:00 Wuhan Wansheng Biotechnology 11,331 +332 RetatrutideRuben (talk | contribs) expand §Distribution and dispatch [rollback]
  3. (diff | hist) 15:44 Talk:Flourishglobal Peptide Biotech 748 +235 ColdChainCleo (talk | contribs) /* State the packing, do not explain it */ reply
  4. (diff | hist) 14:49 Talk:Beyond-use date 885 +318 Compounding_Cate (talk | contribs) /* Category 2 table: which revision, and should earlier revisions be shown? */ reply
  5. (diff | hist) 13:22 Talk:Reconstitution calculator 537 +429 AnalyticalAnnie (talk | contribs) /* Should the default vial mass be the gross or net figure? */ new section
  6. (diff | hist) 11:26 Talk:Beyond-use date 674 +271 PharmDrafts (talk | contribs) /* Category 2 table: which revision, and should earlier revisions be shown? */ new section
  7. (diff | hist) 11:20 Talk:Flourishglobal Peptide Biotech 537 +170 CitationChaser (talk | contribs) /* State the packing, do not explain it */ new section
  8. (diff | hist) 07:37 Enteroendocrine L cell 4,648 ±0 SurpassSunniva (talk | contribs) add short description [rollback]
  9. (diff | hist) 06:22 Missed dose 4,989 +582 ProglucagonPia (talk | contribs) convert the conversion list to a table so the three syringe scales align [rollback]
  10. (diff | hist) 05:10 Xi'an Mokemei Biotechnology 5,251 +159 CheckSumChase (talk | contribs) add the reception tally with its period and count stated [rollback]
  11. (diff | hist) 03:19 Purity claim inflation 4,595 ±0 TB500_Tarquin (talk | contribs) sentence case in headings per PP:MOS [rollback]
  12. (diff | hist) 02:30 Customs seizure 3,644 ±0 API_Aurora (talk | contribs) fix indentation in the source [rollback]
  13. (diff | hist) m b 01:54 Contraindications of incretin therapy 4,296 ±0 StubSorterBot (talk | contribs) bot: add maintenance category [rollback]
  14. (diff | hist) m 01:48 Lyophilisation 21,545 +645 CDMO_Caradoc (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  15. (diff | hist) m 00:22 Limit of detection 4,001 +30 ChromCleanupCass (talk | contribs) rm the vendor name from a methodological sentence [rollback]
  16. (diff | hist) 00:14 Bacterial endotoxin test 4,428 +30 DiluentDiya (talk | contribs) convert the method-comparison paragraph to a table [rollback]

13 May 2025

  1. (diff | hist) 19:46 Nantong Guangyuan Chemical 10,347 +54 ReportReaderRilla (talk | contribs) clarify that no manufacturing or marketing authorisation is claimed or established [rollback]
  2. (diff | hist) 17:50 Triple agonist 3,428 ±0 GlossaryGleb (talk | contribs) fix the amino-acid substitution — position 8, not position 2 [rollback]
  3. (diff | hist) m b 15:03 Liquid chromatography-mass spectrometry 3,724 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) 12:03 Satiety signalling 4,470 +29 Hedgerow_Hal (talk | contribs) rm the causal claim about appetite — the cited work is associative [rollback]
  5. (diff | hist) 10:43 Retatrutide 5,894 ±0 TirzTaxonomist (talk | contribs) add the molecular formula to the infobox [rollback]
  6. (diff | hist) m 10:27 Dual incretin agonist 4,752 +18 LiraLotte (talk | contribs) expand §Design problem [rollback]
  7. (diff | hist) 04:42 Incretin effect 5,933 +165 TirzTaxonomist (talk | contribs) add the enteroendocrine cell type responsible for secretion [rollback]
  8. (diff | hist) 02:41 Reconstitution of lyophilised peptides 5,243 ±0 LyophilLena (talk | contribs) the vial strength in the example was inconsistent between two paragraphs [rollback]
  9. (diff | hist) m 02:07 Repackaging 3,958 ±0 INN_Ingrid (talk | contribs) add the stopper material, since it affects moisture ingress [rollback]

12 May 2025

  1. (diff | hist) 18:18 Cold chain 21,309 +891 FmocFrancis (talk | contribs) unpipe a link that did not need piping [rollback]
  2. (diff | hist) 13:46 Mass spectrometry 5,248 ±0 IsocraticIla (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  3. (diff | hist) m 13:03 Bachem Holding (Suzhou) 10,365 ±0 VerifyVesna (talk | contribs) expand §External links [rollback]
  4. (diff | hist) 00:43 Medutest 3,830 +35 ChromCleanupCass (talk | contribs) correct the description of the sampling procedure [rollback]

11 May 2025

  1. (diff | hist) m 23:21 Certificate of analysis 8,593 +497 BlindSampleBrid (talk | contribs) add category for certificates of analysis [rollback]
  2. (diff | hist) m 21:07 Amylin receptor agonist 3,909 ±0 LiraLotte (talk | contribs) reorder the analogues chronologically rather than alphabetically [rollback]
  3. (diff | hist) 16:18 LEADER trial 3,566 +29 DMF_Dermot (talk | contribs) rm the cross-trial comparison; the populations are not comparable [rollback]
  4. (diff | hist) 14:45 High-performance liquid chromatography 6,203 +156 KarlFischerKit (talk | contribs) give the injection volume, without which the loading cannot be judged [rollback]
  5. (diff | hist) 13:15 GLP-1 receptor 6,670 +252 ExenatideEzra (talk | contribs) convert a hard-coded date to the house format [rollback]
  6. (diff | hist) 12:30 Patent expiry and biosimilars 3,580 ±0 StyleSheetSybil (talk | contribs) rm the speculation about future scheduling [rollback]
  7. (diff | hist) m 08:36 Melanotan II 3,694 +44 Peptide_Pete (talk | contribs) expand §Documented harms [rollback]
  8. (diff | hist) 05:08 Analytical method validation 5,074 +21 SemaglutideSasha (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  9. (diff | hist) 02:40 Amylin 4,252 ±0 ApoB_Aurelio (talk | contribs) add the structural figure and caption it properly [rollback]
  10. (diff | hist) 02:16 List of GLP-1 receptor agonists 3,410 +387 OrphanPageOrin (talk | contribs) consistent en dashes in ranges [rollback]

10 May 2025

  1. (diff | hist) 19:09 Hubei Jianxiang Bioscience 4,829 +1,955 UnderfillUna (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]
  2. (diff | hist) m 18:51 Flourishglobal Peptide Biotech 6,160 +634 DrTitration (talk | contribs) add the see-also to the certificate-of-analysis article [rollback]
  3. (diff | hist) 18:42 Resin cleavage 3,304 +27 Chromatokid (talk | contribs) rm the blanket claim that excursions are harmless [rollback]
  4. (diff | hist) 14:25 Area percent purity 6,569 ±0 MassSpecMarv (talk | contribs) state the column chemistry and the gradient the figure was obtained on [rollback]
  5. (diff | hist) m b 13:02 GL Biochem (Shanghai) 14,316 +539 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  6. (diff | hist) 12:46 Peptide stability table 4,891 +847 DisclosureDido (talk | contribs) move a stray full stop inside the reference [rollback]
  7. (diff | hist) 03:15 Temperature excursion 5,832 +23 SurvodutideSaff (talk | contribs) add the light-exposure point for photosensitive material [rollback]

9 May 2025

  1. (diff | hist) m 22:36 Prior authorisation 3,517 +291 TelehealthTruus (talk | contribs) move a stray full stop inside the reference [rollback]
  2. (diff | hist) m b 21:55 Active pharmaceutical ingredient 3,755 +202 CategoryBot (talk | contribs) bot: update parent category chain [rollback]
  3. (diff | hist) 20:51 Solid-phase peptide synthesis 5,107 ±0 GHK_Gwendolen (talk | contribs) state that a phase-change pack and a gel pack behave differently [rollback]
  4. (diff | hist) 16:18 Sigma-Aldrich (Shanghai) Trading 3,939 +976 NNT_Nerys (talk | contribs) add the lead time for catalogue lines, as reported [rollback]
  5. (diff | hist) 12:50 HOMA-IR 3,431 ±0 FerritinFay (talk | contribs) state which fraction the assay actually measures [rollback]
  6. (diff | hist) 05:50 Trial data comparison 4,355 ±0 Ref_Desk_Ron (talk | contribs) state the rounding rule the readout uses [rollback]
  7. (diff | hist) 03:23 Grey market 3,184 ±0 KarlFischerKit (talk | contribs) state the difference between a validated shipper and an insulated box [rollback]

8 May 2025

  1. (diff | hist) 21:45 Drug master file 3,342 +30 NAION_Noel (talk | contribs) expand §How the mechanism works [rollback]
  2. (diff | hist) 21:26 Hypoglycaemia 3,775 +32 NauseaNoor (talk | contribs) clarify that dose-dependence is reported for some effects and not others [rollback]
  3. (diff | hist) 14:07 Vial 19,742 +506 HOMA_Hettie (talk | contribs) add the stopper material, since it affects moisture ingress [rollback]
  4. (diff | hist) m 11:44 Glucagon 6,042 +288 FreightFenna (talk | contribs) reorder the analogues chronologically rather than alphabetically [rollback]
  5. (diff | hist) 08:33 Talk:Shanghai ERP Biotechnology 959 +296 AnalyticalAnnie (talk | contribs) /* Endotoxin results: worth a paragraph? */ reply
  6. (diff | hist) 07:44 Tirzepatide 7,773 +1,201 MolarMassMaeve (talk | contribs) add a hatnote pointing at the analogue with the similar name [rollback]
  7. (diff | hist) 04:58 Good manufacturing practice 4,901 +982 ListMakerLumi (talk | contribs) clarify that personal importation and commercial importation are different questions [rollback]
  8. (diff | hist) 04:21 Baseline laboratory panel 3,542 +16 ApoB_Aurelio (talk | contribs) expand §Interpretation over time [rollback]
  9. (diff | hist) 02:01 Beta cell function 4,938 +22 Chromatokid (talk | contribs) add the cleavage site by residue number [rollback]

7 May 2025

  1. (diff | hist) m 23:53 Deamidation 4,219 ±0 IsocraticIla (talk | contribs) split overlong sentence [rollback]
  2. (diff | hist) m b 21:55 Beyond-use date 13,672 +541 StubSorterBot (talk | contribs) bot: repair redlinked category [rollback]
  3. (diff | hist) 20:51 Tianjin Finder Chemical 8,089 +456 ColdChainCleo (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  4. (diff | hist) 18:31 Prescribing information 4,324 +641 NauseaNoor (talk | contribs) add the note that list price is rarely what is paid [rollback]
  5. (diff | hist) m 17:54 Cold-chain freight 3,699 ±0 SupplyWatchSuri (talk | contribs) serial comma per PP:MOS [rollback]
  6. (diff | hist) m 15:04 SURPASS trial programme 4,474 ±0 OpenLabelOtto (talk | contribs) correct the endpoint hierarchy — that was a secondary endpoint [rollback]
  7. (diff | hist) 14:56 Janoshik Analytical 4,999 +30 SurpassSunniva (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  8. (diff | hist) m b 13:59 Peptide 5,710 +739 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  9. (diff | hist) 12:50 C-peptide 4,233 +775 UnitsUrsula (talk | contribs) convert the interval table to include both conventional and SI units [rollback]
  10. (diff | hist) 12:44 Talk:Shanghai ERP Biotechnology 748 +210 BlankVialBo (talk | contribs) /* Endotoxin results: worth a paragraph? */ reply
  11. (diff | hist) 09:18 Talk:Shanghai ERP Biotechnology 537 +266 EndotoxinEd (talk | contribs) /* Endotoxin results: worth a paragraph? */ new section
  12. (diff | hist) 09:11 Talk:Area percent purity 1,096 +74 StyleSheetSybil (talk | contribs) /* Should the four unseen categories be a definition list? */ reply
  13. (diff | hist) 08:24 ChinaPeptides 8,933 +1,017 SatietySunniva (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  14. (diff | hist) 08:02 Talk:Lyophilisation 959 +141 SigFigSindri (talk | contribs) /* Vapour-pressure table: source and rounding */ reply
  15. (diff | hist) m b 07:27 Counterfeit peptide 4,235 +233 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]

6 May 2025

  1. (diff | hist) 20:58 ISO 9001 3,379 +39 BalanceBirdie (talk | contribs) expand §What it implies about material [rollback]
  2. (diff | hist) 17:06 Cagrilintide 3,213 +26 LurkerLevi (talk | contribs) give the isoelectric point with the method it was determined by [rollback]